We have summarized data on 233 Alagille syndrome patients reported with mut
ations in Jagged1 (JAG1). This data has been published by seven different l
aboratories in Europe, the United States, Australia, and Japan, Mutations h
ave been demonstrated in 60-75% of patients with a clinically confirmed dia
gnosis of Alagille syndrome. Total gene deletions have been reported in 3-7
% of patients, and the remainder have intragenic mutations. Seventy two per
cent (168/233) of the reported mutations lead to frameshifts that cause a p
remature termination codon. These mutations will either lead to a premature
ly truncated protein, or alternatively, nonsense mediated decay might lead
to lack of a product from that allele. Twenty three unique missense mutatio
ns were identified ( 13% of mutations). These were clustered in conserved r
egions at the 5' end of the gene, or in the EGF repeats. Splicing consensus
sequence changes were identified in 15% of patients. A high frequency of d
e novo mutations (60-70%) has been reported. The spectrum of mutations iden
tified is consistent with haploinsufficiency for JAG1 being a mechanism for
Alagille syndrome. Hum Mutat 17:18-33, 2001. (C) 2001 Wiley Liss, Inc.